|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 269, Issue 6 852-G860, Copyright © 1995 by American Physiological Society
ARTICLES |
R. S. Heller and G. W. Aponte
Department of Nutritional Sciences, University of California, Berkeley 94720-3104, USA.
Glucagon-like peptide (GLP)-1-(7--36) amide, a peptide product of the posttranslational processing of pancreatic and intestinal proglucagon, has been shown to regulate insulin secretion. Monoclonal antibodies to glucagon and GLP-1-(7--36) amide were generated to localize GLP-1-(7--36) amide in the pancreatic islets by immunocytochemistry and radioimmunoassay. GLP-1-(7--36) amide immunoreactivity was found in some, but not all, glucagon-containing alpha-cells. Displaceable receptor binding for GLP-1-(7--36) amide and nonamidated GLP-1-(7--37) on hormone secretion were investigated using isolated pancreatic islet preparations. GLP-1-(7--37) and -(7--36) amide significantly increased insulin and somatostatin release in the concentration range of 0.01-100 nM in 11.0 mM glucose. GLP-1-(7--37) and -(7--36) amide had no effect on glucagon secretion in the presence of 11.0 mM glucose. GLP-1-(7--36) amide was released from isolated islets in response to 2.25, 5.5, and 11.0 mM glucose. These results suggest that pancreatic GLP-1 may be important in the regulation of intra-islet hormone secretion.
This article has been cited by other articles:
![]() |
K. Prasadan, E. Daume, B. Preuett, T. Spilde, A. Bhatia, H. Kobayashi, M. Hembree, P. Manna, and G. K. Gittes Glucagon Is Required for Early Insulin-Positive Differentiation in the Developing Mouse Pancreas Diabetes, November 1, 2002; 51(11): 3229 - 3236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |